Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01720511 · ClinicalTrials.gov registry record · NA
Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation
A NA study of Type 2 Diabetic, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT01720511: Completed NA study of Type 2 Diabetic, sponsored by Pennington Biomedical Research Center.
NCT01720511 is a NA study of Type 2 Diabetic that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01720511, a NA study of Type 2 Diabetic, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to demonstrate the effect of purple rice on post-prandial glucose and insulin. The purple color is due, like red wine grapes, mainly to the anthocyanins. The safety and tolerability of purple rice is similar to white or brown rice, but contains the purple elements common to other foods like grapes.
Primary Outcome
Subjects will have an Intravenous line placed and fasting blood will be drawn. Subjects will then be given glucose to drink and blood will be drawn from an IV line for glucose and insulin.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Purple Rice
- DIETARY_SUPPLEMENT Brown Rice
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-09 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT01720511 record still lists
NCT01720511 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Type 2 Diabetic appearing as the primary indexed condition, and to 2 interventions - of which Purple Rice is the first listed.
NCT01720511 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01720511 about?
NCT01720511 is a clinical study titled "Pilot Study of the Effect of Purple Rice on Glucose Tolerance, Serum Lipids and Inflammation". This is a pilot study to demonstrate the effect of purple rice on post-prandial glucose and insulin. The purple color is due, like red wine grapes, mainly to the anthocyanins. The safety and tolerability of purple rice is similar to white or brown rice, but contains the purple elements common to oth...
What is the current status of trial NCT01720511?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-09. Estimated completion is 2015-10.
What conditions does trial NCT01720511 study?
This clinical trial studies the following conditions: Type 2 Diabetic.
What interventions are being tested in trial NCT01720511?
The interventions under investigation include: Purple Rice (DIETARY_SUPPLEMENT), Brown Rice (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01720511?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01720511 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01720511's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia